Last quarter (Q3 2023), Supernus Pharmaceuticals's total revenue was $153.88M, a decrease of -13.24% from the same quarter last year. In Q3, Supernus Pharmaceuticals's net income was $-15.98M. See Supernus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 610.53M	$ 667.24M	$ 579.77M	$ 520.40M	$ 392.75M	$ 408.90M
Cost of Revenue	$ 215.64M	$ 87.22M	-	$ 52.46M	$ 16.66M	$ 15.36M
Gross Profit	$ 523.43M	$ 580.02M	$ 579.77M	$ 467.94M	$ 376.10M	$ 393.54M
Operating Expense	$ 497.08M	$ 534.40M	$ 500.28M	$ 292.34M	$ 227.52M	$ 249.10M
Operating Income	$ 26.80M	$ 46.12M	$ 79.50M	$ 175.60M	$ 148.57M	$ 144.44M
Net Non Operating Interest Income Expense	$ 7.71M	$ -1.10M	$ 19.70M	$ -5.05M	$ -1.08M	$ -4.27M
Other Income Expense	$ -7.51M	$ -15.13M	$ 6.32M	$ -1.90M	-	-
Pretax Income	$ 36.92M	$ 60.74M	$ 73.17M	$ 168.65M	$ 147.49M	$ 140.18M
Tax Provision	$ 11.30M	$ 32.00K	$ 19.75M	$ 41.70M	$ 34.43M	$ 29.18M
Earnings From Equity Interest Net Of Tax	$ 12.89M	$ 12.89M	-	-	-	-
Net Income Common Stockholders	$ 25.62M	$ 60.71M	$ 53.42M	$ 126.95M	$ 113.06M	$ 110.99M
Basic EPS	$ 0.47	$ 1.13	$ 1.01	$ 2.41	$ 2.16	$ 2.13
Diluted EPS	$ 0.42	$ 1.04	$ 0.98	$ 2.36	$ 2.10	$ 2.05
Basic Average Shares	$ 217.16M	$ 53.67M	$ 53.10M	$ 52.62M	$ 52.41M	$ 51.99M
Diluted Average Shares	$ 233.25M	$ 61.68M	$ 54.36M	$ 53.69M	$ 53.82M	$ 54.10M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 712.73M	$ 621.62M	$ 500.28M	$ 344.80M	$ 244.18M	$ 264.45M
Net Income From Continuing And Discontinued Operation	$ 25.62M	$ 60.71M	$ 53.42M	$ 126.95M	$ 113.06M	$ 110.99M
Normalized Income	$ -25.28M	$ 47.48M	-	$ 128.38M	$ 113.06M	$ 110.99M
Interest Expense	-	-	-	$ 23.75M	$ 22.71M	$ 18.11M
EBIT	$ 29.20M	$ 65.40M	$ 44.68M	$ 192.40M	$ 170.19M	$ 158.29M
EBITDA	$ 113.62M	$ 153.04M	$ 94.77M	$ 210.54M	$ 176.85M	$ 165.35M

Currency in USD

Supernus Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing